Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


06.05.2019

4 Ann Rheum Dis
6 Clin Rheumatol
3 J Rheumatol
1 PLoS One
1 Scand J Rheumatol
1 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. MAROTTE H, Rinaudo-Gaujous M, Petiet C, Fautrel B, et al
    Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study.
    Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215546.
    PubMed     Text format    

  2. TANAKA Y, Fautrel B, Keystone EC, Ortmann RA, et al
    Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2019 Apr 30. pii: annrheumdis-2018-214529.
    PubMed     Text format     Abstract available

  3. TAKEUCHI T, Tanaka Y, Soen S, Yamanaka H, et al
    Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled p
    Ann Rheum Dis. 2019 Apr 29. pii: annrheumdis-2018-214827.
    PubMed     Text format     Abstract available

  4. SPILIOPOULOU A, Colombo M, Plant D, Nair N, et al
    Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39.
    Ann Rheum Dis. 2019 Apr 29. pii: annrheumdis-2018-214877.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  5. KRASSELT M, Baerwald C, Liebert UG, Seifert O, et al
    Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 26. pii: 10.1007/s10067-019-04563.
    PubMed     Text format     Abstract available

  6. BYKERK VP, Ostor AJK, Alvaro-Gracia J, Pavelka K, et al
    Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
    Clin Rheumatol. 2019 Apr 26. pii: 10.1007/s10067-019-04535.
    PubMed     Text format     Abstract available

  7. LEE GY, Kim S, Choi ST, Song JS, et al
    The superb microvascular imaging is more sensitive than conventional power Doppler imaging in detection of active synovitis in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Apr 27. pii: 10.1007/s10067-019-04550.
    PubMed     Text format     Abstract available

  8. SUH CH, Jung JY, Oh H, Boo S, et al
    Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2019 Apr 29. pii: 10.1007/s10067-019-04559.
    PubMed     Text format     Abstract available

  9. JOO YB, Park YJ, Park KS, Kim KJ, et al
    Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 2. pii: 10.1007/s10067-019-04554.
    PubMed     Text format     Abstract available

  10. COHEN SB, Kremer JM, Dandreo KJ, Reed GW, et al
    Outcomes of infliximab dose escalation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 May 2. pii: 10.1007/s10067-019-04543.
    PubMed     Text format     Abstract available


    J Rheumatol

  11. CARVALHO PD, Ferreira RJO, Landewe R, Vega-Morales D, et al
    Association of seventeen definitions of remission with functional status in a large clinical practice cohort of patients with rheumatoid arthritis.
    J Rheumatol. 2019 May 1. pii: jrheum.181286. doi: 10.3899/jrheum.181286.
    PubMed     Text format     Abstract available

  12. KEELING S, Bowker S, Savu A, Kaul P, et al
    A Population Level Analysis of the Differing Impacts of Rheumatoid Arthritis and Spondyloarthritis on Peripartum Outcomes.
    J Rheumatol. 2019 May 1. pii: jrheum.181320. doi: 10.3899/jrheum.181320.
    PubMed     Text format     Abstract available

  13. BECHMAN K, Yates M, Norton S, Cope A, et al
    Placebo response in rheumatoid arthritis clinical trials.
    J Rheumatol. 2019 May 1. pii: jrheum.190008. doi: 10.3899/jrheum.190008.
    PubMed     Text format     Abstract available


    PLoS One

  14. GARCIA-MORENO C, Gomara MJ, Bleda MJ, Sanmarti R, et al
    Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis.
    PLoS One. 2019;14:e0215927.
    PubMed     Text format     Abstract available


    Scand J Rheumatol

  15. MELLBLOM BENGTSSON M, Hagel S, Jacobsson L, Turesson C, et al
    Lower extremity function in patients with early rheumatoid arthritis during the first five years, and relation to other disease parameters.
    Scand J Rheumatol. 2019 Apr 29:1-8. doi: 10.1080/03009742.2019.1579859.
    PubMed     Text format     Abstract available


    Z Rheumatol

  16. KRUGER K, Kneitz C
    [Comorbidities-Their role in the treat to target concept for rheumatoid arthritis].
    Z Rheumatol. 2019 May 2. pii: 10.1007/s00393-019-0637.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: